Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtlantic Lithium Regulatory News (ALL)

Share Price Information for Atlantic Lithium (ALL)

Share Price is delayed by 15 minutes
Get Live Data
16.45    0.00 (0.00%)
Bid:
0.00
Ask:
16.90
Spread: 0.45 (2.736%)
Market Cap: £131.85m
ALL Live PriceLast checked at - London Stock Exchange

Intraday Atlantic Lithium Share Chart

Offer Update

5 Nov 2014 14:50

RNS Number : 2571W
Allocate Software PLC
05 November 2014
 



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM, CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

5 November 2014

OFFER UPDATE

for

Allocate Software Plc ("Allocate" or the "Company")by

Acorn Bidco Limited ("Bidco")

 

On 3 November 2014, the board of Allocate announced that it had received a request from a second potential competing offeror on 31 October 2014, pursuant to Rule 20.2 of the Code, requiring that any information provided to Bidco be given equally and promptly to them. In accordance with Rule 2.6(e) of the Code, the board of Allocate now announces that it has received confirmation that this second potential competing offeror does not intend to make an offer for the Company and is therefore now subject to the restrictions as set out in Rule 2.8 of the Code.

 

The board of Allocate continues to recommend the cash offer by Bidco for Allocate (the "Offer") and reminds Allocate's shareholders that the first closing date of the Offer is 1.00 pm (London time) on 26 November 2014.

  

 

 

Shareholder helpline

A helpline is available for Allocate Shareholders on 0871 664 0300 if calling from within the United Kingdom or, if calling from outside the United Kingdom, +44 20 8639 3399. Calls to the helpline from the UK cost 10 pence per minute from a BT landline. Other network providers' costs may vary. Lines are open from 9.00 a.m. to 5.30 p.m. Monday to Friday (except English bank holidays). Calls to the helpline from outside the UK will be charged at the applicable international rate. Different charges may apply to calls from mobile telephones and calls may be recorded and randomly monitored for security and training purposes. The helpline cannot provide advice on the merits of the Offer nor give any financial, legal or tax advice.

 

Enquiries:

Allocate Software Plc

Tel: +44 20 7355 5555

Ian Bowles (Chief Executive Officer)

Chris Gale (Chief Financial Officer)

 

William Blair International, Ltd. (lead financial adviser and Rule 3 adviser to Allocate)

Tel: +44 20 7868 4444

Raphael Grunschlag / Oliver Parker

 

Numis Securities Limited (broker, joint financial adviser and Nominated Adviser to Allocate)

Tel: +44 20 7260 1000

Simon Willis / Richard Thomas (Corporate Finance)

James Black (Corporate Broking)

 

FTI Consulting (media enquiries in respect of Allocate)

Tel: +44 20 3727 1000

Matt Dixon / Chris Lane

 

 

Important Notices

William Blair International, Ltd, which is regulated by the FCA in the United Kingdom, is acting as lead financial adviser to Allocate and no-one else in relation to the subject matter of this announcement and will not be responsible to anyone other than Allocate for providing the protections afforded to clients of William Blair nor for providing advice in relation to the subject matter of this announcement.

Numis Securities Limited, which is authorised and regulated by the FCA in the United Kingdom, is acting as joint financial adviser, nominated adviser and corporate broker to Allocate and no-one else in relation to the subject matter of this announcement and will not regard any other person as its client in relation to the subject matter of this announcement and will not be responsible to anyone other than Allocate for providing the protections afforded to clients of Numis nor for providing advice in relation to the subject matter of this announcement.

This announcement is for information purposes only and does not constitute an offer to sell or an invitation to purchase any securities or the solicitation of an offer to buy any securities, pursuant to the Offer or otherwise. The Offer shall be made solely by means of the Offer Document which shall contain the full terms and Conditions of the Offer, including details of how to vote in respect of the acquisition.

This announcement has been prepared for the purpose of complying with English law and the Code and the information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws of jurisdictions outside the United Kingdom.

The Offer shall be subject to the applicable requirements of the Code, the AIM Rules, the Panel, the London Stock Exchange and the Financial Conduct Authority.

This announcement does not constitute a prospectus or prospectus equivalent document.

Overseas Shareholders

The release, publication or distribution of this announcement in or into any jurisdiction other than the United Kingdom may be restricted by law and the availability of the Offer to Allocate Shareholders who are not resident in the United Kingdom may be restricted by the laws of the relevant jurisdiction in which they are located. Such persons should inform themselves of, and observe, all applicable legal and regulatory requirements of their jurisdictions. Any failure to comply with the requirements of such jurisdictions may constitute a violation of the securities laws of such jurisdictions. To the fullest extent permitted by applicable law, the companies and persons involved in the Offer disclaim any responsibility or liability for the violation of such restrictions by any person. This announcement has been prepared for the purposes of complying with English law, the rules of the London Stock Exchange and the Code and the information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws of jurisdictions other than England and Wales.

This announcement is not intended to and does not constitute, or form part of, any offer to sell or issue or an invitation to purchase or subscribe for any securities or a solicitation of an offer to buy any securities pursuant to this announcement or otherwise in any jurisdiction in which such offer or solicitation is unlawful.

The Offer will not be made, directly or indirectly, in or into, any Restricted Jurisdiction. Accordingly, copies of this announcement and formal documentation relating to the Offer are not being, and must not be, directly or indirectly, mailed or otherwise forwarded, transmitted, distributed, sent or accessed in or into or from any Restricted Jurisdiction. Persons receiving this announcement (including without limitation custodians, nominees and trustees) should observe these restrictions and must not mail or otherwise forward, transmit, distribute or send it in or into or from any Restricted Jurisdiction.

Forward-Looking Statements

This announcement (including information incorporated by reference in this announcement), oral statements made regarding the Offer and other information published by Allocate may contain statements which are, or may be deemed to be, "forward-looking statements". Often, but not always, forward-looking statements can be identified by the use of forward-looking words such as "will", "shall", "may", "should", "continue", "believe", "expect", "intend", "anticipate", "forecast", "plan" and "project" or similar expressions. Such statements reflect the relevant company's or person's current views with respect to future events and are subject to risks, assumptions and uncertainties that could cause the actual results to differ materially from those expressed or implied by such forward-looking statements.

Many of these risks, assumptions and uncertainties relate to factors that are beyond the companies' or relevant persons' abilities to control or estimate precisely, including the following: future market conditions, changes in general economic and business conditions, regulatory changes, the behaviour of other market participants, litigation, weak, volatile or illiquid capital and/or credit markets, interest rate and currency value fluctuations, the degree of competition in the geographic and business areas in which Allocate operate and changes in laws or in supervisory expectations or requirements. Other unknown or unpredictable factors could also cause actual results to differ materially from those in the forward-looking statements. Allocate cannot give any assurance that the forward-looking statements will prove to have been correct. You should not, therefore, place undue reliance on these forward-looking statements, which speak only as of the date of this announcement. Allocate does not undertake any obligation to update or revise publicly any of the forward-looking statements set out in this announcement, whether as a result of new information, future events or otherwise, except to the extent legally required.

Allocate nor any of its respective associates or directors, officers or advisers, provides any representation, assurance or guarantee that the occurrence of the events expressed or implied in any forward-looking statements in this announcement (including the information incorporated by reference into this announcement) will actually occur. You are cautioned not to place undue reliance on these forward-looking statements which speak only as of the date hereof.

No profit forecasts or estimates

No statement in this announcement or incorporated by reference into this announcement is intended as a profit forecast or estimate for any period and no statement in this announcement should be interpreted to mean that earnings or earnings per share for Allocate, as appropriate, for the current or future financial years would necessarily match or exceed the historical published earnings or earnings per share for Allocate.

Disclosure requirements of the Code

Under Rule 8.3(a) of the Code, any person who is interested in 1 per cent. or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified. An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 p.m. (London time) on the 10th Business Day following the commencement of the offer period and, if appropriate, by no later than 3.30 p.m. (London time) on the 10th Business Day following the announcement in which any securities exchange offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a securities exchange offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1 per cent. or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror, save to the extent that these details have previously been disclosed under Rule 8 of the Code. A Dealing Disclosure by a person to whom Rule 8.3(b) of the Code applies must be made by no later than 3.30 p.m. (London time) on the Business Day following the date of the relevant dealing.

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3 of the Code.

Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4 of the Code).

Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Panel's website at http://www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. You should contact the Panel's Market Surveillance Unit on +44 20 7638 0129 if you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure.

Electronic Communications

Please be aware that addresses, electronic addresses and certain other information provided by Allocate Shareholders and other relevant persons for the receipt of communications from Allocate may be provided to Bidco during the Offer Period as required under Section 4 of Appendix 4 of the Code.

Publication on Website and Availability of Hard Copies

In accordance with Rule 30.4 of the Code, a copy of this announcement together with all information incorporated into this announcement by reference to another source will be available, subject to certain restrictions relating to persons resident in Restricted Jurisdictions, on Allocate's website (www.allocatesoftware.com) by no later than 12 noon (London time) on the Business Day following the publication of this announcement. For the avoidance of doubt, the contents of those websites are not incorporated by reference and do not form part of this announcement.

 

Rule 2.10 Disclosure

 

In accordance with Rule 2.10 of the Code, Allocate confirms that as at the date of this announcement, it has in issue and admitted to trading on AIM 68,300,539 ordinary shares of £0.05

each (excluding ordinary shares held in treasury). The International Securities Identification Number (ISIN) of the ordinary shares is GB0004368766.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEALFSELSLFFF
Date   Source Headline
30th Mar 20237:00 amRNSConference Attendance
24th Mar 20237:00 amRNSCorporate Update - Director/PDMR Shareholding
22nd Mar 20237:00 amRNSDefinitive Feasibility Study Project Update
20th Mar 20237:00 amRNS2023 Exploration and Resource Programmes Update
20th Mar 20237:00 amRNSDirector/PDMR Shareholding
17th Mar 20237:05 amRNSInvestor Presentation
17th Mar 20237:00 amRNSHolding(s) in Company
15th Mar 20237:00 amRNSCorporate Update and Half-year Financial Report
9th Mar 20238:15 amRNSRestoration - Atlantic Lithium Limited
9th Mar 20238:00 amRNSResponse to Online Report & Restoration of Trading
8th Mar 20234:15 pmRNSSuspension - Atlantic Lithium Limited
1st Mar 20238:00 amRNSResults of Extraordinary General Meeting
21st Feb 20237:00 amRNSCommunications Update - Conference Attendance
17th Feb 20237:00 amRNSExpression of Interest - Investment by MIIF
13th Feb 20239:00 amRNSRicca Resources - Pre-IPO Placement
3rd Feb 20238:00 amRNSCorporate Communication Update Mining Indaba 2023
1st Feb 20237:00 amRNSEwoyaa Mineral Resource increases to 35.3Mt
31st Jan 20237:00 amRNSNotice of Extraordinary General Meeting
30th Jan 20237:00 amRNSQuarterly Activities and Cash Flow Report Dec 2022
20th Jan 20237:00 amRNSCorporate Update – 2023 OTCQX Best 50 - ALLIF
12th Jan 20237:00 amRNSFinal Assay Results and New High-Grade pegmatites
30th Dec 20228:00 amRNSCorporate Update Change of terms for Share Options
13th Dec 20227:00 amRNSPrimero awarded FEED Contract for Ewoyaa Lithium
5th Dec 20227:00 amRNSCommunication Update - LSE Investor Webinar
30th Nov 20227:15 amRNSCorporate Update - Result of 2022 AGM
29th Nov 20227:00 amRNSHigh-Grade Drill Results - Highest Grade to Date
28th Nov 20227:00 amRNSAppointment of Alternate Director
28th Nov 20227:00 amRNSCommencement of COO and Issue of Options
22nd Nov 20227:00 amRNSTR1 Notification of Major Holdings
16th Nov 20227:00 amRNSCorporate Update - Mines & Money London 2022
9th Nov 20227:38 amRNSSignificant Potential for Resource Upgrades
2nd Nov 20227:00 amRNSHighest Reported Grade to Date of 4.52% Li2O
31st Oct 20227:00 amRNSNotice of AGM
27th Oct 20227:10 amRNSAppointment of Chief Operating Officer
27th Oct 20227:05 amRNSQuarterly Activities and Cash Flow Report
27th Oct 20227:00 amRNSInvestor Presentation for Webinar
21st Oct 20227:00 amRNSCorporate Communication Update - Investor Webinar
20th Oct 20227:00 amRNSOngoing High-Grade Lithium Intersections at Ewoyaa
13th Oct 20227:00 amRNSMining Licence Application Lodged for Ewoyaa
12th Oct 20227:00 amRNSCorporate Update - Conference Attendance
30th Sep 20227:30 amRNSCorporate Update – 2022 Annual Financial Report
28th Sep 202210:00 amRNSPiedmont Partner Atlantic Lithium Completes PFS
26th Sep 202210:00 amRNSASX Listing – Commencement of Trading
22nd Sep 20227:00 amRNSRobust Ewoyaa Pre-Feasibility Study
21st Sep 20227:01 amRNSASX Listing – Admission to Official List
19th Sep 20227:00 amRNSCorporate Update - Issue of Equity / PCA Dealings
16th Sep 20222:00 pmRNSTR1 Notification of Significant Shareholding
8th Sep 202210:00 amRNSCorporate Update Dual Listing – Close of ASX Offer
30th Aug 202212:00 pmRNSCorporate Communication Update - Africa Down Under
30th Aug 202210:00 amRNSLodgement of Dual Listing Replacement Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.